Elizabeth A Platz
Platz, Elizabeth A.
VIAF ID: 7152682499123311362 (Personal)
Permalink: http://viaf.org/viaf/7152682499123311362
Preferred Forms
- 100 0 _ ‡a Elizabeth A Platz
-
- 100 1 _ ‡a Platz, Elizabeth A.
- 100 1 _ ‡a Platz, Elizabeth A.
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
Energy balance and prostate cancer, 2018: | |
PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy | |
Race and colorectal cancer screening compliance among persons with a family history of cancer | |
Racial Difference in Prostate Cancer Cell Telomere Lengths in Men with Higher Grade Prostate Cancer: A Clue to the Racial Disparity in Prostate Cancer Outcomes | |
Racial differences in maternal and umbilical cord blood leukocyte telomere length and their correlations | |
Racial/Ethnic Differences in the Associations of Overall and Central Body Fatness with Circulating Hormones and Metabolic Factors in US Men. | |
Racial variation in vitamin D cord blood concentration in white and black male neonates | |
Re: "a prospective study of statin drug use and lower urinary tract symptoms in older men". Author reply | |
Re: Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia. | |
Re: "Obesity and hormone-dependent tumors: cohort and co-twin control studies based on the Swedish twin registry" | |
Re: The association between statins and cancer incidence in a veterans population | |
Recommended definitions of aggressive prostate cancer for etiologic epidemiologic research | |
Reducing Cancer Burden in the Population: An Overview of Epidemiologic Evidence to Support Policies, Systems, and Environmental Changes | |
Reflections on success in multidisciplinary, translational science: working together to answer the right questions | |
Relationship of sex steroid hormones with bone mineral density of the lumbar spine in adult men | |
Response to the letter "Is albuminuria related to later cancer in subjects with diabetes?" | |
Risk factors for prostate cancer incidence and progression in the health professionals follow-up study | |
The role of obesity in cancer survival and recurrence | |
Screening Prostate-specific Antigen Concentration and Prostate Cancer Mortality: The Korean Heart Study. | |
Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome | |
Selenium and Prostate Cancer: Analysis of Individual Participant Data From Fifteen Prospective Studies | |
Selenium, genetic variation, and prostate cancer risk: epidemiology reflects back on selenium and vitamin E cancer prevention trial | |
SERPINA1 and ELA2 polymorphisms are not associated with COPD or lung cancer | |
Serum estrogen, but not testosterone, levels differ between black and white men in a nationally representative sample of Americans | |
Serum prostate-specific antigen (PSA) concentration is positively associated with rate of disease reclassification on subsequent active surveillance prostate biopsy in men with low PSA density | |
Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy | |
Serum Urate, Genetic Variation, and Prostate Cancer Risk: Atherosclerosis Risk in Communities (ARIC) Study | |
SES and correlated factors do not explain the association between periodontal disease, edentulism, and cancer risk | |
Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era. | |
Sexually transmitted diseases among users of erectile dysfunction drugs | |
Sexually transmitted infections and prostatic inflammation/cell damage as measured by serum prostate specific antigen concentration | |
Sexually Transmitted Infections, Prostatitis, Ejaculation Frequency, and the Odds of Lower Urinary Tract Symptoms | |
Shift from pStat6 to pStat3 predominance is associated with inflammatory bowel disease-associated dysplasia | |
Short- and long-term risk of colorectal adenoma recurrence among whites and blacks | |
Statin drug use is not associated with prostate cancer risk in men who are regularly screened | |
Statin drugs, serum cholesterol, and prostate-specific antigen in the National Health and Nutrition Examination Survey 2001-2004. | |
Statin medication use and the risk of biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database | |
Stronger association between obesity and biochemical progression after radical prostatectomy among men treated in the last 10 years | |
Sustained influence of infections on prostate-specific antigen concentration: An analysis of changes over 10 years of follow-up | |
Telomere length as a risk factor for hereditary prostate cancer | |
Telomere length assessment in human archival tissues: combined telomere fluorescence in situ hybridization and immunostaining | |
Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis. | |
Temporal stability and age-related prevalence of loss of imprinting of the insulin-like growth factor-2 gene | |
TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomas | |
To adjust or not in studies on racial differences in hormone concentrations? Depends on the question! | |
Trajectory of overall health from self-report and factors contributing to health declines among cancer survivors | |
Transition of a clinical trial into translational research: the prostate cancer prevention trial experience. | |
Trefoil factor 3 overexpression in prostatic carcinoma: prognostic importance using tissue microarrays | |
Trends in sex hormone concentrations in US males: 1988-1991 to 1999-2004. | |
Trichomonas vaginalis infection and prostate-specific antigen concentration: Insights into prostate involvement and prostate disease risk | |
Using Patients' Social Network to Improve Compliance to Outpatient Screening Colonoscopy Appointments Among Blacks: A Randomized Clinical Trial | |
The V89L polymorphism in the 5alpha-reductase type 2 gene and risk of prostate cancer | |
Variants in the -Methylacyl-CoA Racemase Gene and the Association with Advanced Distal Colorectal Adenoma | |
Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial | |
Variations in plasma lycopene and specific isomers over time in a cohort of U.S. men | |
Vertex balding, plasma insulin-like growth factor 1, and insulin-like growth factor binding protein 3. | |
Viral infections and lower urinary tract symptoms in the third national health and nutrition examination survey | |
Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and prostate cancer risk | |
Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study | |
Weight gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA era. | |
What can geography tell us about prostate cancer? | |
When is enough, enough? When are more observational epidemiologic studies needed to resolve a research question: illustrations using biomarker-cancer associations |